Simplex Trading, LLC Catalyst Pharmaceuticals, Inc. Transaction History

Simplex Trading, LLC

$2.81 Billion
Q3 2024

A detailed history of Simplex Trading, LLC transactions in Catalyst Pharmaceuticals, Inc. stock. As of the latest transaction made, Simplex Trading, LLC holds 2,986 shares of CPRX stock, worth $65,453. This represents 0.0% of its overall portfolio holdings.

Number of Shares

2,986

Previous 2,633 13.41%

Holding current value

$65,453

Previous $40,000 47.5%

% of portfolio

0.0%

Previous 0.0%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 08, 2024	BUY	$15.19 - $21.35 $5,362 - $7,536	353 Added 13.41%	2,986 $59,000
Q2 2024 Jul 25, 2024	BUY	$14.68 - $16.92 $38,652 - $44,550	2,633 New	2,633 $40,000
Q4 2023 Feb 02, 2024	BUY	$11.78 - $17.29 $238,038 - $349,379	20,207 Added 2330.68%	21,074 $354,000
Q3 2023 Nov 01, 2023	SELL	$11.69 - $15.02 $101,738 - $130,719	-8,703 Reduced 90.94%	867 $10,000
Q2 2023 Aug 04, 2023	BUY	$11.5 - $18.08 $110,055 - $173,025	9,570 New	9,570 $128,000
Q4 2022 Feb 02, 2023	BUY	$12.25 - $19.5 $35,831 - $57,037	2,925 Added 36.22%	11,001 $204,000
Q3 2022 Nov 04, 2022	BUY	$7.06 - $15.52 $36,154 - $79,477	5,121 Added 173.3%	8,076 $103,000
Q2 2022 Aug 03, 2022	SELL	$6.23 - $8.57 $111,909 - $153,942	-17,963 Reduced 85.87%	2,955 $20,000
Q1 2022 May 02, 2022	BUY	$5.31 - $8.31 $91,475 - $143,156	17,227 Added 466.73%	20,918 $173,000
Q4 2021 Feb 23, 2022	SELL	$5.21 - $7.45 $384,023 - $549,132	-73,709 Reduced 95.23%	3,691 $24,000
Q3 2021 Oct 28, 2021	SELL	$4.85 - $6.04 $1,939 - $2,416	-400 Reduced 0.51%	77,400 $448,000
Q2 2021 Aug 12, 2021	BUY	$4.29 - $6.05 $300,484 - $423,760	70,043 Added 902.97%	77,800 $447,000
Q1 2021 Apr 26, 2021	SELL	$3.45 - $4.69 $98,749 - $134,241	-28,623 Reduced 78.68%	7,757 $35,000
Q4 2020 Feb 02, 2021	BUY	$2.97 - $3.83 $108,048 - $139,335	36,380 New	36,380 $121,000
Q3 2020 Oct 14, 2020	SELL	$2.97 - $5.08 $27,223 - $46,563	-9,166 Closed	0 $0
Q2 2020 Jul 13, 2020	SELL	$3.48 - $5.05 $63,353 - $91,935	-18,205 Reduced 66.51%	9,166 $42,000
Q1 2020 Apr 29, 2020	SELL	$2.61 - $5.21 $116,559 - $232,673	-44,659 Reduced 62.0%	27,371 $105,000
Q4 2019 Feb 05, 2020	SELL	$3.67 - $5.7 $36,413 - $56,555	-9,922 Reduced 12.11%	72,030 $270,000
Q3 2019 Oct 15, 2019	BUY	$3.89 - $7.43 $267,624 - $511,169	68,798 Added 523.02%	81,952 $435,000
Q2 2019 Jul 26, 2019	SELL	$2.7 - $6.11 $41,528 - $93,977	-15,381 Reduced 53.9%	13,154 $50,000
Q1 2019 Apr 18, 2019	BUY	$2.11 - $5.33 $53,893 - $136,138	25,542 Added 853.39%	28,535 $0
Q4 2018 Jan 16, 2019	SELL	$1.92 - $3.62 $11,715 - $22,089	-6,102 Reduced 67.09%	2,993 $5,000
Q3 2018 Oct 23, 2018	BUY	$2.81 - $3.78 $25,556 - $34,379	9,095 New	9,095 $34,000
Q1 2018 Apr 26, 2018	SELL	$2.39 - $4.01 $2,657 - $4,459	-1,112 Closed	0 $0
Q4 2017 Jan 10, 2018	SELL	$2.51 - $4.4 $3,468 - $6,080	-1,382 Reduced 55.41%	1,112 $4,000
Q3 2017 Oct 25, 2017	BUY	$2.4 - $2.94 $5,985 - $7,332	2,494	2,494 $6,000

Others Institutions Holding CPRX

# of Institutions

325

Shares Held

94.1M

Call Options Held

19.1K

Put Options Held

51.1K

View Full List

About CATALYST PHARMACEUTICALS, INC.

Ticker CPRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 102,820,000
Market Cap $2.25B
Description
Catalyst Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies for people with rare debilitating, chronic neuromuscular, and neurological diseases in the United States. It offers Firdapse, an amifampridine phosphate tablets for the treatment of patients with lambert-eaton myasthe...

More about CPRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Simplex Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Simplex Trading, LLC with notifications on news.

Account

Simplex Trading, LLC Catalyst Pharmaceuticals, Inc. Transaction History